Pharma Excipients
Sugars
Easy, fast and reliable! – Product Overview by Biogrund
Excellent excipient premixes for film coating, sugar-coating, coloring and tableting. Tailor-made & ready-to-use.
Easy, fast and reliable application with BIOGRUND products. For accelerated process times and always reproducible results.
Welcome to BIOGRUND
We assist the pharmaceutical and…
Read More...
Read More...
Impact of Excipients Blending on Sugar-Stabilized Therapeutic Proteins
Abstract
Sugars have long been used as stabilizing excipients for protein-based therapeutics during the development and production process. Incorporating stabilizing agents, such as sucrose and trehalose into dry formulations is a common strategy approved by the US FDA. However, single-sugar…
Read More...
Read More...
Transdermal Delivery of Pramipexole Using Microneedle Technology for the Potential Treatment of…
Parkinson’s disease (PD) is a debilitating neurodegenerative disease primarily impacting neurons responsible for dopamine production within the brain. Pramipexole (PRA) is a dopamine agonist that is currently available in tablet form. However, individuals with PD commonly encounter difficulties with…
Read More...
Read More...
Medication Lubricants for Oral Delivery of Drugs: Oral Processing Reduces Thickness, Changes…
Abstract
Swallowing oral solid dosage forms is challenging for those who have medication swallowing difficulties, including patients with dysphagia. One option is to mix the drug (whole or crushed) with a thick vehicle (medication lubricant). Previous in vitro studies consistently suggest that…
Read More...
Read More...
Fabrication of Orally Fast Disintegrating Wafer Tablets Containing Cannabis Extract Using Freeze…
Abstract
Introduction: The development of a novel dosage form for cannabis extract is necessary to improve drug delivery
and to also enhance patient convenience.
Methods: Orally fast disintegrating wafer tablets containing cannabis extract, which were prepared using the
freeze drying…
Read More...
Read More...
Colon-targeted delivery systems of budesonide as second-line therapy in inflammatory bowel disease
Abstract
In inflammatory bowel disease (IBD), some parts of the gastrointestinal tract GIT become inflamed, depending on the location of the inflammation, it's divided into two types Crohn's and ulcerative colitis (UC). The local absorption of anti-inflammatory drugs such as budesonide (BUD) at the…
Read More...
Read More...
Tableting of coated multiparticulates: Influences of punch face configurations
Abstract
The influences of the punch face design on multi-unit pellet system (MUPS) tablets were investigated. Drug-loaded pellets coated with sustained release polymer based on ethylcellulose or acrylic were compacted into MUPS tablets. Punch face designs used include standard concave, deep…
Read More...
Read More...
Taste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with…
Abstract
Orally disintegrating granules (ODGs) are a pharmaceutical form commonly used for the administration of NSAIDs because of their easy assumption and fast dispersion. The development of ODGs is not easy for drugs like dexketoprofen trometamol (DXKT), which have a bitter and burning taste. In…
Read More...
Read More...
Potentially Harmful Excipients: State of the Art for Oral Liquid Forms Used in Neonatology and…
Abstract
The pediatric population exhibits an important age-dependent heterogeneity in pharmacokinetics and pharmacodynamics parameters, resulting in differences in drug efficacy and toxicity compared to the adult population, particularly for neonates. Toxicity and efficacy divergences have been…
Read More...
Read More...
Design, development and scale up studies of metformin hydrochloride multiparticulate system: A…
Metformin hydrochloride (MH) is prescribed for treating diabetes mellitus. The most popular dosage form, viz., tablets has a bulky nature as MH dose ranges up to 1000 mg leading to large size. In geriatric or dysphagic patients, due to altered physiology, swallowing such bulky formulation is…
Read More...
Read More...